Catherine Sazdanoff - 29 Dec 2021 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Director
Signature
/s/ Bruce Colwill, attorney-in-fact for Mrs. Catherine Sazdanoff
Issuer symbol
INM
Transactions as of
29 Dec 2021
Net transactions value
$0
Form type
4
Filing time
30 Dec 2021, 17:03:21 UTC
Next filing
28 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 +7,000 +32% $0.000000 29,091 29 Dec 2021 Common shares 7,000 $1.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 12/29/2021 and will vest 100% on the one year anniversary of the grant date (Dec 29, 2022) or immediately prior to the next AGM, whichever is sooner.